Next Article in Journal
Discrepancies in Recommendations on Pharmacokinetic Drug Interactions for Anticancer Medications and Direct Oral Anticoagulants (DOAC): A Comparative Analysis of Different Clinical Decision Support Systems and Sources
Next Article in Special Issue
SGLT2 Inhibitors in MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) Associated with Sustained Hepatic Benefits, Besides the Cardiometabolic
Previous Article in Journal
Matrix Metalloproteinase-2-Responsive Peptide-Modified Cleavable PEGylated Liposomes for Paclitaxel Delivery
Previous Article in Special Issue
Analysis of Scyllo-Inositol in a Wistar Rat Animal Model—A Preliminary Study
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(7), 1043; https://doi.org/10.3390/ph18071043
Action Date Notes Link
article xml file uploaded 15 July 2025 17:21 CEST Original file -
article xml uploaded. 15 July 2025 17:21 CEST Update -
article pdf uploaded. 15 July 2025 17:21 CEST Version of Record https://www.mdpi.com/1424-8247/18/7/1043/pdf-vor
article supplementary file uploaded. 15 July 2025 17:21 CEST - https://www.mdpi.com/1424-8247/18/7/1043#supplementary
article html file updated 15 July 2025 17:22 CEST Original file -
article xml file uploaded 23 July 2025 10:51 CEST Update -
article xml uploaded. 23 July 2025 10:51 CEST Update https://www.mdpi.com/1424-8247/18/7/1043/xml
article pdf uploaded. 23 July 2025 10:51 CEST Updated version of record https://www.mdpi.com/1424-8247/18/7/1043/pdf
article html file updated 23 July 2025 10:53 CEST Update https://www.mdpi.com/1424-8247/18/7/1043/html
Back to TopTop